CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $1.4B, above the global median of $548.88M
- FinancialsAltman Z-Score 3.61: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.37%Below 5Y avg (0.47%)
Annual Rate
JPY 13.00Paid semi-annual
Payout Ratio
5.0%Sustainable
Next Ex-Dividend
Dec 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
158.36BJPY1.01B · vs all stocks (USD)
Trailing P/E
13.46xvs Pharmaceutical Retailers peers
Revenue (TTM)
220.64BJPY1.40B · vs all stocks (USD)
Profit Margin
3.57%vs Pharmaceutical Retailers peers
Beta
0.4890xvs all stocks
52-Week Change
-29.69%vs all stocks
Forward Annual Dividend Yield
0.37%vs all stocks
Market Capitalization
158.36BJPY1.01B · vs all stocks (USD)
Enterprise Value
137.63BJPY875.19M · vs all stocks (USD)
Trailing P/E
13.46xvs Pharmaceutical Retailers peers
Forward P/E
13.43xvs Pharmaceutical Retailers peers
PEG Ratio
1.40xPrice to Sales (TTM)
0.4799xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.72xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.6240xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
7.75xvs Pharmaceutical Retailers peers
Profit Margin
3.57%vs Pharmaceutical Retailers peers
Operating Margin
4.86%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
4.87%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
13.72%vs Pharmaceutical Retailers peers
Revenue (TTM)
220.64BJPY1.40B · vs all stocks (USD)
Revenue per Share (TTM)
7.24KJPYUpdated Sep 22, 2026Quarterly Revenue Growth
10.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
44.92BJPY285.66M · vs all stocks (USD)
EBITDA (TTM)
18.60BJPY118.30M · vs all stocks (USD)
Net Income (TTM)
7.87BJPY50.08M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.80%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
16.97BJPY107.94M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-5.00BJPY-31.83M · vs all stocks (USD)
Forward Annual Dividend Rate
13.00JPYUpdated Sep 22, 2026Forward Annual Dividend Yield
0.37%vs all stocks
Trailing Annual Dividend Rate
13.00JPYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.37%vs all stocks
5-Year Average Dividend Yield
0.47%vs all stocks
Payout Ratio
5.04%vs Pharmaceutical Retailers peers
Revenue
200.79BJPYFY2025 · Jun 30, 2025Cost of Goods Sold
159.90BJPYFY2025 · Jun 30, 2025Gross Profit
40.89BJPYFY2025 · Jun 30, 2025Operating Income
9.66BJPY61.41M · vs all stocks (USD)
Pre-tax Income
9.90BJPYFY2025 · Jun 30, 2025Income Tax Expense
2.84BJPYFY2025 · Jun 30, 2025Net Income
7.07BJPYFY2025 · Jun 30, 2025EBIT
10.12BJPYFY2025 · Jun 30, 2025EBITDA (Income Statement)
16.41BJPYFY2025 · Jun 30, 2025Non-operating Interest Income
10.00MJPYFY2025 · Jun 30, 2025Non-operating Interest Expense
216.00MJPYFY2025 · Jun 30, 2025EPS (Basic)
232.51JPYFY2025 · Jun 30, 2025EPS (Diluted)
232.04JPYFY2025 · Jun 30, 2025Basic Shares Outstanding
30.39MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
30.39MSharesFY2025 · Jun 30, 2025Preferred Stock Dividends
0.00JPYFY2025 · Jun 30, 2025Operating Cash Flow
6.80BJPYFY2025 · Jun 30, 2025Free Cash Flow
-8.27BJPYFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
6.22BJPYFY2025 · Jun 30, 2025Starting Profit (CF Statement)
9.90BJPYFY2025 · Jun 30, 2025Other Non-cash Items
66.00MJPYFY2025 · Jun 30, 2025Change in Accounts Receivable (CF)
-151.00MJPYFY2025 · Jun 30, 2025Change in Other Assets/Liabilities
-3.01BJPYFY2025 · Jun 30, 2025Capital Expenditures
-15.07BJPYFY2025 · Jun 30, 2025Net Intangibles (CF)
-15.00MJPYFY2025 · Jun 30, 2025Purchase of Investments
0.00JPYFY2025 · Jun 30, 2025Sale of Investments
0.00JPYFY2025 · Jun 30, 2025Other Investing Activity
-531.00MJPYFY2025 · Jun 30, 2025Net Investing Cash Flow
-15.60BJPYFY2025 · Jun 30, 2025Long-term Debt Issuance
13.00BJPYFY2025 · Jun 30, 2025Long-term Debt Payments
-9.27BJPYFY2025 · Jun 30, 2025Common Stock Repurchase
0.00JPYFY2025 · Jun 30, 2025Common Dividends Paid
-395.00MJPYFY2025 · Jun 30, 2025Other Financing Charges
-2.00MJPYFY2025 · Jun 30, 2025Net Financing Cash Flow
3.35BJPYFY2025 · Jun 30, 2025Shares Outstanding
30.51MSharesUpdated Sep 22, 2026Float Shares
15.58MSharesUpdated Sep 22, 2026% Held by Insiders
46.50%vs all stocks
% Held by Institutions
24.50%vs all stocks
Total Cash (MRQ)
7.87BJPY50.02M · vs all stocks (USD)
Total Cash per Share (MRQ)
257.84JPYUpdated Sep 22, 2026Total Debt (MRQ)
39.64BJPY252.07M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6459xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
0.9280xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
2.01KJPYUpdated Sep 22, 2026Total Assets
127.32BJPY809.62M · vs all stocks (USD)
Total Current Assets
41.21BJPYFY2025 · Jun 30, 2025Total Liabilities
73.90BJPYFY2025 · Jun 30, 2025Total Non-current Assets
86.11BJPYFY2025 · Jun 30, 2025Total Non-current Liabilities
30.09BJPYFY2025 · Jun 30, 2025Total Current Liabilities
43.81BJPYFY2025 · Jun 30, 2025Cash & Cash Equivalents
6.22BJPYFY2025 · Jun 30, 2025Accounts Receivable
4.84BJPYFY2025 · Jun 30, 2025Inventory
27.07BJPYFY2025 · Jun 30, 2025Accounts Payable
26.73BJPYFY2025 · Jun 30, 2025Short-term Debt
8.42BJPYFY2025 · Jun 30, 2025Other Current Liabilities
834.00MJPYFY2025 · Jun 30, 2025Long-term Debt
25.96BJPYFY2025 · Jun 30, 2025Other Non-current Liabilities
335.00MJPYFY2025 · Jun 30, 2025Common Stock (Book)
1.03BJPYFY2025 · Jun 30, 2025Retained Earnings
46.53BJPYFY2025 · Jun 30, 2025Total Shareholders' Equity
53.43BJPY339.74M · vs all stocks (USD)
Treasury Stock
790.00MJPYFY2025 · Jun 30, 202552-Week Low
3.17KJPYUpdated Sep 22, 202652-Week High
5.46KJPYUpdated Sep 22, 202652-Week Change
-29.69%vs all stocks
Beta
0.4890xvs all stocks
50-Day MA
3.66KJPYUpdated Sep 22, 2026200-Day MA
3.98KJPYUpdated Sep 22, 2026Avg 10-Day Volume
60.88KSharesUpdated Sep 22, 2026Avg 30-Day Volume
70.36KSharesUpdated Sep 22, 2026Diluted EPS (TTM)
257.82JPYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.61: safe zoneNotable
Altman Z-Score: 3.61
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $1.4B, above the global median of $548.88MNotable
Revenue (USD): 1,403,014,998.548Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
BLS International Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Oriental Holdings Berhad
Tier 1FlowUnit ReplicationInterfaceRisk
Yixintang Pharmaceutical Group Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Chengdu Hongqi Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Abdullah Al Othaim Markets
Tier 1FlowUnit ReplicationInterfaceProduction
Aoki Holdings Inc.
Tier 1FlowUnit ReplicationRiskInterface
Grocery Outlet Holding Corp
Tier 1FlowUnit ReplicationInterfaceProduction
Carter's Inc.
Tier 1FlowUnit ReplicationRiskInterface
Anhui Huaren Health Pharmaceutical Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Shanghai Waigaoqiao Free Trade Zone Development Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Tianjin Ringpu Bio-Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Five-Star Business Finance Limited
1 interpretationMulti-Year Revenue, Profit, And Income Growth